1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Autoimmune Drug Focus JULY 2015

Autoimmune Drug Focus JULY 2015

  • July 2015
  • -
  • Espicom Business Intelligence
  • -
  • 24 pages

Industry Trend Analysis - Actemra/RoActemra Sales Will Overtake MabThera/Rituxan In Roche's Immunology Portfolio In FY15
Industry Brief - Novo Nordisk To Cease Tresiba's Distribution In Germany
Industry Brief - Levemir Receives Positive CHMP Opinion For Use In Children As Young As One
Industry Brief - Perle Reports Enrolment In Insulin Independence Phase III Trial
Industry Trend Analysis - Next-Generation Insulin Patch In The Making
Industry Brief - Sanofi's Lantus XR Approved In Japan
Industry Brief - First Patient Dosed In Midaform Insulin PharmFilm Phase IIa Study
Industry Brief - Immune Pharmaceuticals Initiates Bertilimumab Phase II Trials In UC/Bullous Pemphigoid
Industry Brief - RedHill Granted US Patent Allowances Covering RHB-104 Phase III CD Programme
Industry Brief - Qu Biologics Begins Phase II Trial In UC
Industry Brief - RedHill's RHB-104 Phase III CD Study Granted Clearance In Australia/New Zealand
Industry Brief - Tillotts To Acquire Ex-US Global Rights For Entocort From AstraZeneca
Industry Trend Analysis - Entocort Acquisition Will Improve Tillotts' Acquisition Profile
Industry Trend Analysis - Ovasave's Success Depends On Improving Existing CD Treatments
Industry Brief - TxCell's Ovasave Gains FDA Fast Track Designation For CD
Industry Trend Analysis - Genentech's Ocrelizumab Will Be Used In Second-Line MS
Industry Brief - Ablynx/Taisho Sign Japanese Ozoralizumab Licensing Deal For RA
Industry Brief - Teva/Active Biotech Report Completion Of Patient Enrolment In Laquinimod Phase III Trial
Industry Brief - Simponi Receives EC Approval For Nr-Axial SpA
Industry Brief - Novartis' Cosentyx Shows Sustained Efficacy Over One Year In PsA Patients
Industry Brief - FDA Accepts Xeljanz NDA For Moderate-To-Severe RA
Industry Brief - MTP Files Application For Partial Change In Dosage/Usage Of Remicade In Psoriasis
Industry Trend Analysis - Remsima On Course To Be A Global Biosimilar
Industry Brief - KHK Reports Results From KHK4827 Japanese Phase III Studies In Psoriasis
Industry Brief - Adcetris Phase II Trial Initiated In Lupus
Industry Brief - Gevokizumab Phase III Trial In Behçet's disease Misses Primary Endpoint
Industry Brief - Epratuzumab Phase III Trial Programme In SLE Misses Primary Endpoints
Industry Brief - Biogen Plans New Production Plant In Switzerland
Industry Trend Analysis - Receptos Acquisition Will Enhance Celgene's Blockbuster Autoimmune Expectations
Industry Trend Analysis - M&A Activity Ahead For Biogen
Industry Brief - Eisai To Transfer North Carolina Plant To Biogen
Industry Brief - Autoimmune Conferences - October 2015

Table Of Contents

Autoimmune Drug Focus JULY 2015

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
2017 World Clinical Chemistry Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East—Over 100 Special Chemistry, Abused Drugs, Endocrine, Immunoprotein, TDM, Tumor MarkerTests--Supplier Shares, Competitive Strategies, Opportunities

2017 World Clinical Chemistry Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East—Over 100 Special Chemistry, Abused Drugs, Endocrine, Immunoprotein, TDM, Tumor MarkerTests--Supplier Shares, Competitive Strategies, Opportunities

  • $ 75000
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in both ...

2017 World Cancer Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

2017 World Cancer Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

  • $ 52400
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic ...

2017 World Tumor Marker Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

2017 World Tumor Marker Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

  • $ 52400
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic ...


ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.